 | | BQD | | Name: | (3R)-N-(6-bromonaphthalen-2-yl)-3-hydroxy-1-propanoyl-L-prolinamide | | Formula: | C18 H19 Br N2 O3 | | SMILES: | C3C(C(C(=O)Nc2cc1ccc(cc1cc2)Br)N(C(CC)=O)C3)O | | InChi: | InChI=1S/C18H19BrN2O3/c1-2-16(23)21-8-7-15(22)17(21)18(24)20-14-6-4-11-9-13(19)5-3-12(11)10-14/h3-6,9-10,15,17,22H,2,7-8H2,1H3,(H,20,24)/t15-,17+/m1/s1 | | Definition date: | 2017-08-23 | | Last modified: | 2018-01-26 | | Release date: | 2018-01-31 | | Identifier: | (3R)-N-(6-bromonaphthalen-2-yl)-3-hydroxy-1-propanoyl-L-prolinamide |
|
 | | 8KL | | Name: | 9-O-3'-quinolinium propylberberine | | Formula: | C31 H28 N2 O4 | | SMILES: | COc1ccc2cc3c4cc5OCOc5cc4CC[n+]3cc2c1OCCC[n+]6cccc7ccccc67 | | InChi: | InChI=1S/C31H28N2O4/c1-34-28-10-9-22-16-27-24-18-30-29(36-20-37-30)17-23(24)11-14-33(27)19-25(22)31(28)35-15-5-13-32-12-4-7-21-6-2-3-8-26(21)32/h2-4,6-10,12,16-19H,5,11,13-15,20H2,1H3/q+2 | | Definition date: | 2017-07-26 | | Last modified: | 2018-01-19 | | Release date: | 2018-01-24 |
|
 | | 9XW | | Name: | ~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide | | Formula: | C19 H26 N4 O4 S | | SMILES: | COc1ccc(N2CCOCC2)c3sc(NC(=O)N4CCC(C)(O)CC4)nc13 | | InChi: | InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24) | | Definition date: | 2017-07-28 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | ~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide |
|
 | | CVV | | Name: | N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide | | Formula: | C27 H27 I N2 O3 | | SMILES: | N(C4C=CC1C2Cc6ccc(c5c6C1(CCN2CC3CC3)C4O5)O)C(c7cc(ccc7)I)=O | | InChi: | InChI=1S/C27H27IN2O3/c28-18-3-1-2-17(12-18)26(32)29-20-8-7-19-21-13-16-6-9-22(31)24-23(16)27(19,25(20)33-24)10-11-30(21)14-15-4-5-15/h1-3,6-9,12,15,19-21,25,31H,4-5,10-11,13-14H2,(H,29,32)/t19-,20+,21+,25-,27-/m0/s1 | | Definition date: | 2017-10-04 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide |
|
 | | DYV | | Name: | 1-(3-chloro-4-{[1-(2-hydroxy-3-methoxyphenyl)-5-oxo[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl]methyl}benzene-1-carbonyl)-L-proline | | Formula: | C29 H24 Cl N5 O6 | | SMILES: | c1ccc2c(c1)n5c(N(C2=O)Cc3c(cc(cc3)C(=O)N4CCCC4C(O)=O)Cl)nnc5c6cccc(c6O)OC | | InChi: | InChI=1S/C29H24ClN5O6/c1-41-23-10-4-7-19(24(23)36)25-31-32-29-34(27(38)18-6-2-3-8-21(18)35(25)29)15-17-12-11-16(14-20(17)30)26(37)33-13-5-9-22(33)28(39)40/h2-4,6-8,10-12,14,22,36H,5,9,13,15H2,1H3,(H,39,40)/t22-/m0/s1 | | Definition date: | 2017-11-17 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 1-(3-chloro-4-{[1-(2-hydroxy-3-methoxyphenyl)-5-oxo[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl]methyl}benzene-1-carbonyl)-L-proline |
|
 | | DZS | | Name: | 3-{4-[(2-chlorophenyl)methyl]-5-oxo-4,5-dihydro[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-4-hydroxybenzoic acid | | Formula: | C23 H15 Cl N4 O4 | | SMILES: | c2cc1C(=O)N(c4n(c1cc2)c(c3cc(C(O)=O)ccc3O)nn4)Cc5c(cccc5)Cl | | InChi: | InChI=1S/C23H15ClN4O4/c24-17-7-3-1-5-14(17)12-27-21(30)15-6-2-4-8-18(15)28-20(25-26-23(27)28)16-11-13(22(31)32)9-10-19(16)29/h1-11,29H,12H2,(H,31,32) | | Definition date: | 2017-11-17 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 3-{4-[(2-chlorophenyl)methyl]-5-oxo-4,5-dihydro[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-4-hydroxybenzoic acid |
|
 | | DZV | | Name: | 4-[(2-chlorophenyl)methyl]-1-(2-hydroxy-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one | | Formula: | C23 H17 Cl N4 O3 | | SMILES: | C(c1c(cccc1)Cl)N2c5n(c3c(C2=O)cccc3)c(c4cccc(c4O)OC)nn5 | | InChi: | InChI=1S/C23H17ClN4O3/c1-31-19-12-6-9-16(20(19)29)21-25-26-23-27(13-14-7-2-4-10-17(14)24)22(30)15-8-3-5-11-18(15)28(21)23/h2-12,29H,13H2,1H3 | | Definition date: | 2017-11-19 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 4-[(2-chlorophenyl)methyl]-1-(2-hydroxy-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one |
|
 | | 6TV | | Name: | ~{N}-[2-(propylamino)ethyl]isoquinoline-5-sulfonamide | | Formula: | C14 H19 N3 O2 S | | SMILES: | CCCNCCN[S](=O)(=O)c1cccc2cnccc12 | | InChi: | InChI=1S/C14H19N3O2S/c1-2-7-15-9-10-17-20(18,19)14-5-3-4-12-11-16-8-6-13(12)14/h3-6,8,11,15,17H,2,7,9-10H2,1H3 | | Definition date: | 2016-06-22 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | ~{N}-[2-(propylamino)ethyl]isoquinoline-5-sulfonamide |
|
 | | 6TX | | Name: | 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium | | Formula: | C14 H20 N3 O2 S | | SMILES: | CCCN(CC[NH3+])[S](=O)(=O)c1cccc2cnccc12 | | InChi: | InChI=1S/C14H19N3O2S/c1-2-9-17(10-7-15)20(18,19)14-5-3-4-12-11-16-8-6-13(12)14/h3-6,8,11H,2,7,9-10,15H2,1H3/p+1 | | Definition date: | 2016-06-22 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium |
|
 | | 6TY | | Name: | 5-[(2~{R})-2-methylpiperazin-1-yl]sulfonylisoquinoline | | Formula: | C14 H17 N3 O2 S | | SMILES: | C[CH]1CNCCN1[S](=O)(=O)c2cccc3cnccc23 | | InChi: | InChI=1S/C14H17N3O2S/c1-11-9-16-7-8-17(11)20(18,19)14-4-2-3-12-10-15-6-5-13(12)14/h2-6,10-11,16H,7-9H2,1H3/t11-/m1/s1 | | Definition date: | 2016-06-22 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 5-[(2~{R})-2-methylpiperazin-1-yl]sulfonylisoquinoline |
|
 | | 83S | | Name: | 5-Hydroxy-4-(isoindoline-2-carbonyl)-2-isopropylbenzaldehyde | | Formula: | C19 H19 N O3 | | SMILES: | C2c1c(cccc1)CN2C(c3cc(C(C)C)c(C=O)cc3O)=O | | InChi: | InChI=1S/C19H19NO3/c1-12(2)16-8-17(18(22)7-15(16)11-21)19(23)20-9-13-5-3-4-6-14(13)10-20/h3-8,11-12,22H,9-10H2,1-2H3 | | Definition date: | 2016-12-22 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 4-(1,3-dihydro-2H-isoindole-2-carbonyl)-5-hydroxy-2-(propan-2-yl)benzaldehyde |
|
 | | 85P | | Name: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid | | Formula: | C16 H9 Cl F N O5 S | | SMILES: | c1(ccc3c(c1)c(C(O)=O)cc(c2ccc(cc2)Cl)n3)OS(F)(=O)=O | | InChi: | InChI=1S/C16H9ClFNO5S/c17-10-3-1-9(2-4-10)15-8-13(16(20)21)12-7-11(24-25(18,22)23)5-6-14(12)19-15/h1-8H,(H,20,21) | | Definition date: | 2017-01-05 | | Last modified: | 2018-01-12 | | Release date: | 2018-01-17 | | Identifier: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid |
|
 | | U3M | | Name: | 3-quinolin-6-yl-5-quinolin-7-yl-benzoic acid | | Formula: | C25 H16 N2 O2 | | SMILES: | OC(=O)c1cc(cc(c1)c2ccc3cccnc3c2)c4ccc5ncccc5c4 | | InChi: | InChI=1S/C25H16N2O2/c28-25(29)22-13-20(17-7-8-23-19(11-17)4-2-9-26-23)12-21(14-22)18-6-5-16-3-1-10-27-24(16)15-18/h1-15H,(H,28,29) | | Definition date: | 2017-07-27 | | Last modified: | 2018-01-05 | | Release date: | 2018-01-10 | | Identifier: | 3-quinolin-6-yl-5-quinolin-7-yl-benzoic acid |
|
 | | AVM | | Name: | 3-(3-acetamidophenyl)-5-quinolin-7-yl-benzoic acid | | Formula: | C24 H18 N2 O3 | | SMILES: | CC(=O)Nc1cccc(c1)c2cc(cc(c2)c3ccc4cccnc4c3)C(O)=O | | InChi: | InChI=1S/C24H18N2O3/c1-15(27)26-22-6-2-4-17(13-22)19-10-20(12-21(11-19)24(28)29)18-8-7-16-5-3-9-25-23(16)14-18/h2-14H,1H3,(H,26,27)(H,28,29) | | Definition date: | 2017-07-27 | | Last modified: | 2018-01-05 | | Release date: | 2018-01-10 | | Identifier: | 3-(3-acetamidophenyl)-5-quinolin-7-yl-benzoic acid |
|
 | | 8UM | | Name: | 5-[(5S)-5-ethyl-5-methyl-6-oxo-1,4,5,6-tetrahydropyridin-3-yl]-N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)thiophene-2-sulfonamide | | Formula: | C21 H20 F N3 O4 S2 | | SMILES: | c3(NS(c2ccc(C1=CNC(=O)C(C1)(C)CC)s2)(=O)=O)cc4c(cc3F)C=CNC4=O | | InChi: | InChI=1S/C21H20FN3O4S2/c1-3-21(2)10-13(11-24-20(21)27)17-4-5-18(30-17)31(28,29)25-16-9-14-12(8-15(16)22)6-7-23-19(14)26/h4-9,11,25H,3,10H2,1-2H3,(H,23,26)(H,24,27)/t21-/m0/s1 | | Definition date: | 2017-03-03 | | Last modified: | 2018-01-05 | | Release date: | 2018-01-10 | | Identifier: | 5-[(5S)-5-ethyl-5-methyl-6-oxo-1,4,5,6-tetrahydropyridin-3-yl]-N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)thiophene-2-sulfonamide |
|
 | | 8US | | Name: | N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide | | Formula: | C17 H16 F N3 O4 S2 | | SMILES: | c3(NS(c1ccc(s1)N2CCC(C2)O)(=O)=O)cc4c(cc3F)C=CNC4=O | | InChi: | InChI=1S/C17H16FN3O4S2/c18-13-7-10-3-5-19-17(23)12(10)8-14(13)20-27(24,25)16-2-1-15(26-16)21-6-4-11(22)9-21/h1-3,5,7-8,11,20,22H,4,6,9H2,(H,19,23)/t11-/m1/s1 | | Definition date: | 2017-03-03 | | Last modified: | 2018-01-05 | | Release date: | 2018-01-10 | | Identifier: | N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide |
|
 | | Q92 | | Name: | 3-quinolin-6-ylbenzoic acid | | Formula: | C16 H11 N O2 | | SMILES: | OC(=O)c1cccc(c1)c2ccc3ncccc3c2 | | InChi: | InChI=1S/C16H11NO2/c18-16(19)14-4-1-3-11(10-14)12-6-7-15-13(9-12)5-2-8-17-15/h1-10H,(H,18,19) | | Definition date: | 2017-07-27 | | Last modified: | 2018-01-05 | | Release date: | 2018-01-10 | | Identifier: | 3-quinolin-6-ylbenzoic acid |
|
 | | CQN | | Name: | Bepridil | | Formula: | C24 H34 N2 O | | SMILES: | CC(C)COC[CH](CN(Cc1ccccc1)c2ccccc2)N3CCCC3 | | InChi: | InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3/t24-/m1/s1 | | Definition date: | 2017-12-03 | | Last modified: | 2017-12-29 | | Release date: | 2018-01-03 | | Identifier: | ~{N}-[(2~{R})-3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]-~{N}-(phenylmethyl)aniline |
|
 | | 9WA | | Name: | (R)-(4-chloro-2-methoxy-3-{[4-(1H-pyrazol-1-yl)phenyl]methyl}quinolin-6-yl)(1-methyl-1H-imidazol-5-yl)[6-(trifluoromethyl)pyridin-3-yl]methanol | | Formula: | C31 H24 Cl F3 N6 O2 | | SMILES: | c1cc4c(cc1C(c2ccc(nc2)C(F)(F)F)(c3cncn3C)O)c(c(c(n4)OC)Cc5ccc(cc5)n6cccn6)Cl | | InChi: | InChI=1S/C31H24ClF3N6O2/c1-40-18-36-17-27(40)30(42,21-7-11-26(37-16-21)31(33,34)35)20-6-10-25-23(15-20)28(32)24(29(39-25)43-2)14-19-4-8-22(9-5-19)41-13-3-12-38-41/h3-13,15-18,42H,14H2,1-2H3/t30-/m1/s1 | | Definition date: | 2017-06-16 | | Last modified: | 2017-12-22 | | Release date: | 2017-12-27 | | Identifier: | (R)-(4-chloro-2-methoxy-3-{[4-(1H-pyrazol-1-yl)phenyl]methyl}quinolin-6-yl)(1-methyl-1H-imidazol-5-yl)[6-(trifluoromethyl)pyridin-3-yl]methanol |
|
 | | 9WD | | Name: | 1-{4-[(R)-(4-chloro-2-methoxy-3-{[4-(1H-pyrazol-1-yl)phenyl]methyl}quinolin-6-yl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl]piperidin-1-yl}ethan-1-one | | Formula: | C32 H33 Cl N6 O3 | | SMILES: | c4(c(OC)nc3ccc(C(c1cncn1C)(O)C2CCN(C(C)=O)CC2)cc3c4Cl)Cc6ccc(n5nccc5)cc6 | | InChi: | InChI=1S/C32H33ClN6O3/c1-21(40)38-15-11-23(12-16-38)32(41,29-19-34-20-37(29)2)24-7-10-28-26(18-24)30(33)27(31(36-28)42-3)17-22-5-8-25(9-6-22)39-14-4-13-35-39/h4-10,13-14,18-20,23,41H,11-12,15-17H2,1-3H3/t32-/m1/s1 | | Definition date: | 2017-06-16 | | Last modified: | 2017-12-22 | | Release date: | 2017-12-27 | | Identifier: | 1-{4-[(R)-(4-chloro-2-methoxy-3-{[4-(1H-pyrazol-1-yl)phenyl]methyl}quinolin-6-yl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl]piperidin-1-yl}ethan-1-one |
|
 | | CJD | | Name: | 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one | | Formula: | C22 H24 Cl2 N2 O5 | | SMILES: | c12c(cc(c(c1C(=O)N(CC2)CC3=C(C=C(C)NC3=O)OC)Cl)C(C4COC4)OC)Cl | | InChi: | InChI=1S/C22H24Cl2N2O5/c1-11-6-17(29-2)15(21(27)25-11)8-26-5-4-13-16(23)7-14(19(24)18(13)22(26)28)20(30-3)12-9-31-10-12/h6-7,12,20H,4-5,8-10H2,1-3H3,(H,25,27)/t20-/m1/s1 | | Definition date: | 2017-09-26 | | Last modified: | 2017-12-22 | | Release date: | 2017-12-27 | | Identifier: | 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one |
|
 | | CJG | | Name: | 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one | | Formula: | C22 H21 Cl2 N3 O3 | | SMILES: | c1(cc(c(c2c1CCN(C2=O)CC3=C(C=C(C)NC3=O)C)Cl)c4c(noc4C)C)Cl | | InChi: | InChI=1S/C22H21Cl2N3O3/c1-10-7-11(2)25-21(28)16(10)9-27-6-5-14-17(23)8-15(20(24)19(14)22(27)29)18-12(3)26-30-13(18)4/h7-8H,5-6,9H2,1-4H3,(H,25,28) | | Definition date: | 2017-09-26 | | Last modified: | 2017-12-22 | | Release date: | 2017-12-27 | | Identifier: | 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one |
|
 | | BFV | | Name: | N-benzyl-1-{3-[(2-chloro-5-{5-(methylsulfonyl)-1-[3-(morpholin-4-yl)propyl]-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl}phenyl)ethynyl]phenyl}methanamine | | Formula: | C36 H40 Cl N5 O3 S | | SMILES: | C1COCCN1CCCn5c6c(c(c4ccc(Cl)c(C#Cc2cccc(c2)CNCc3ccccc3)c4)n5)CN(CC6)S(C)(=O)=O | | InChi: | InChI=1S/C36H40ClN5O3S/c1-46(43,44)41-18-15-35-33(27-41)36(39-42(35)17-6-16-40-19-21-45-22-20-40)32-13-14-34(37)31(24-32)12-11-28-9-5-10-30(23-28)26-38-25-29-7-3-2-4-8-29/h2-5,7-10,13-14,23-24,38H,6,15-22,25-27H2,1H3 | | Definition date: | 2017-08-08 | | Last modified: | 2017-12-15 | | Release date: | 2017-12-20 | | Identifier: | N-benzyl-1-{3-[(2-chloro-5-{5-(methylsulfonyl)-1-[3-(morpholin-4-yl)propyl]-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl}phenyl)ethynyl]phenyl}methanamine |
|
 | | BGY | | Name: | tert-butyl 4-(2-{3-(4-chloro-3-iodophenyl)-1-[3-(morpholin-4-yl)propyl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-2-oxoethyl)piperidine-1-carboxylate | | Formula: | C31 H43 Cl I N5 O4 | | SMILES: | C(CCn2c3c(c(c1cc(c(cc1)Cl)I)n2)CN(CC3)C(=O)CC4CCN(CC4)C(=O)OC(C)(C)C)N5CCOCC5 | | InChi: | InChI=1S/C31H43ClIN5O4/c1-31(2,3)42-30(40)36-12-7-22(8-13-36)19-28(39)37-14-9-27-24(21-37)29(23-5-6-25(32)26(33)20-23)34-38(27)11-4-10-35-15-17-41-18-16-35/h5-6,20,22H,4,7-19,21H2,1-3H3 | | Definition date: | 2017-08-08 | | Last modified: | 2017-12-15 | | Release date: | 2017-12-20 | | Identifier: | tert-butyl 4-(2-{3-(4-chloro-3-iodophenyl)-1-[3-(morpholin-4-yl)propyl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-2-oxoethyl)piperidine-1-carboxylate |
|
 | | BHJ | | Name: | {(3S)-7-[(2-chloro-5-{5-(methylsulfonyl)-1-[3-(morpholin-4-yl)propyl]-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl}phenyl)ethynyl]-1,2,3,4-tetrahydroisoquinolin-3-yl}(piperidin-1-yl)methanone | | Formula: | C37 H45 Cl N6 O4 S | | SMILES: | C7N(CCCn5c6c(c(c1ccc(c(c1)C#Cc2ccc3c(c2)CNC(C3)C(N4CCCCC4)=O)Cl)n5)CN(CC6)S(C)(=O)=O)CCOC7 | | InChi: | InChI=1S/C37H45ClN6O4S/c1-49(46,47)43-17-12-35-32(26-43)36(40-44(35)16-5-13-41-18-20-48-21-19-41)30-10-11-33(38)29(23-30)9-7-27-6-8-28-24-34(39-25-31(28)22-27)37(45)42-14-3-2-4-15-42/h6,8,10-11,22-23,34,39H,2-5,12-21,24-26H2,1H3/t34-/m0/s1 | | Definition date: | 2017-08-08 | | Last modified: | 2017-12-15 | | Release date: | 2017-12-20 | | Identifier: | {(3S)-7-[(2-chloro-5-{5-(methylsulfonyl)-1-[3-(morpholin-4-yl)propyl]-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl}phenyl)ethynyl]-1,2,3,4-tetrahydroisoquinolin-3-yl}(piperidin-1-yl)methanone |
|
